Gregory L. Kucera, Ph.D., Associate Professor Internal Medicine-Hematology and Oncology

Gregory L. Kucera, Ph.D.

Associate Core Director, Comprehensive Cancer Center
Associate Professor, Hematology & Oncology
Comprehensive Cancer Center
Cancer Biology
Physiology & Pharmacology

Contact Information

Academic: 336-716-6348 | Department: 336-716-4464

Email: gkucera@wakehealth.edu

Education & Training

Ph.D., Wake Forest University , 1987
B.S., Davidson College , 1982
Fellowship, University of Vermont, 1990

Gregory L. Kucera, Ph.D.

Associate Core Director, Comprehensive Cancer Center
Associate Professor, Hematology & Oncology Comprehensive Cancer Center
Cancer Biology
Physiology & Pharmacology

Contact Information

Academic: 336-716-6348 | Department: 336-716-4464

Email: gkucera@wakehealth.edu

Recent Publications

Ding S, Qiao X, Kucera GL, Bierbach U. Design of a platinum-acridine-endoxifen conjugate targeted at hormone-dependent breast cancer. Chem Commun (Camb). 2013;49(24):2415-2417.

Morris-Natschke SL, Fleming RA, Kucera GL, inventors; Wake Forest University Health Sciences, assignee. Novel phospholipid conjugates double-targeted HIV. United States Patent US 8,138,200. 2012 Mar 20. 2012;():.

Qiao X, Zeitany AE, Wright MW, Essader AS, Levine KE, Kucera GL, Bierbach U. Analysis of the DNA damage produced by a platinum-acridine antitumor agent and its effects in NCI-H460 lung cancer cells. Metallomics. 2012;4(7):645-652.

Ding S, Qiao X, Kucera GL, Bierbach U. Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents. J Med Chem. 2012;55(22):10198-203.

Graham LA, Suryadi J, West TK, Kucera GL, Bierbach U. Synthesis, aqueous reactivity, and biological evaluation of carboxylic acid ester-functionalized platinum-acridine hybrid anticancer agents. J Med Chem. 2012;55(17):7817-7827.

Pickard AJ, West TK, Kucera GL, Bierbach U. Biomedical applications of targeting platinum conjugates to DNA secondary structural motifs [abstract]. Abstr Pap Am Chem Soc. 2011;241():161-INOR.

Smyre CL, Saluta G, Kute TE, Kucera GL, Bierbach U. Inhibition of DNA synthesis by a platinum-acridine hybrid agent leads to potent cell kill in nonsmall cell lung cancer. ACS Med Chem Lett. 2011;2(11):870-874.

Graham LA, Wilson GM, West TK, Day CS, Kucera GL, Bierbach U. Unusual reactivity of a potent platinum-acridine hybrid antitumor agent. ACS Med Chem Lett. 2011;2(9):687-691.

Rao L, West TK, Saluta G, Kucera GL, Bierbach U. Probing platinum-adenine-n3 adduct formation with DNA minor-groove binding agents. Chem Res Toxicol. 2010;23(7):1148-1150.

Pickin KA, Alexander RL, Morrow CS, Morris-Natschke SL, Ishaq KS, Fleming RA, Kucera GL. Phospholipid/deoxycytidine analogue prodrugs for the treatment of cancer. J Drug Del Sci Tech. 2009;19(1):31-36.

Eiter LC, Hall NW, Day CS, Saluta G, Kucera GL, Bierbach U. Gold(I) analogues of a platinum-acridine antitumor agent are only moderately cytotoxic but show potent activity against Mycobacterium tuberculosis. J Med Chem. 2009;52(21):6519-6522.

Kheradi AR, Saluta G, Kucera GL, Day CS, Bierbach U. Synthesis and biological evaluation of platinum-acridine hybrid agents modified with bipyridine non-leaving groups. Bioorg Med Chem Lett. 2009;19(13):3423-3425.

Kucera L, Fleming R, Ishaq K, Kucera G, Morris-Natschke S, inventors; Wake Forest University Health Sciences, assignee. Compositions and methods for targeting cancer cells. United States patent US 7,638,528. 2009 Dec 29. 2009;():.

Choudhury JR, Guddneppanavar R, Saluta G, Kucera GL, Bierbach U. Tuning the DNA conformational perturbations induced by cytotoxic platinum-acridine bisintercalators: effect of metal cis/trans isomerism and DNA threading groups. J Med Chem. 2008;51(11):3069-3072.

Ma Z, Saluta G, Kucera GL, Bierbach U. Effect of linkage geometry on biological activity in thiourea- and guanidine-substituted acridines and platinum-acridines. Bioorg Med Chem Lett. 2008;18(13):3799-3801.

Ma Z, Choudhury JR, Wright MW, Day CS, Saluta G, Kucera GL, Bierbach U. A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer. J Med Chem. 2008;51(23):7574-7580.

Barnes AP, Miller BE, Kucera GL. Cyclooxygenase inhibition and hyperthermia for the potentiation of the cytotoxic response in ovarian cancer cells. Gynecol Oncol. 2007;104(2):443-450.

Park G, Tomlinson JT, Misenheimer JA, Kucera GL, Manderville RA. Photo-induced cytotoxicity of prodigiosin analogues. Bull Korean Chem Soc. 2007;28(1):49-52.

Guddneppanavar R, Choudhury JR, Kheradi AR, Steen BD, Saluta G, Kucera GL, Day CS, Bierbach U. Effect of the diamine nonleaving group in platinum--acridinylthiourea conjugates on DNA damage and cytotoxicity. J Med Chem. 2007;50(9):2259-2263.

Lentz SS, Miller BE, Kucera GL, Levine EA. Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma. Gynecol Oncol. 2007;106(1):207-210.

Kucera L, Ishaq K, Morris-Natsche S, Kucera G, Fleming R, inventors; Wake Forest University Health Sciences, assignee. Compositions and methods for targeting cancer cells. Unites States patent US 7,309,696. 2007 Dec 18. 2007;():.

Tomlinson JT, Park G, Misenheimer JA, Kucera GL, Hesp K, Manderville RA. Photoinduced cytotoxicity and thioadduct formation by a prodigiosin analogue. Org Lett. 2006;8(21):4951-4954.